Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 6.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:33
on 2023/05/30 09:33
Change comment:
There is no comment for this version
To version 5.11
edited by Sarantis Dimitriadis
on 2022/06/07 10:26
on 2022/06/07 10:26
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -106,8 +106,11 @@ 106 106 (% class="western" lang="en-GB" %) 107 107 (% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table . 108 108 109 -(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %) 110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups** 109 +(% style="margin-left:auto; margin-right:auto" %) 110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)((( 111 +(% class="western" lang="en-GB" style="text-align:center" %) 112 +(% lang="en-US" %)**Age or age group** 113 +))) 111 111 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 112 112 (% lang="en-US" %)Specific age range 113 113 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( ... ... @@ -119,47 +119,145 @@ 119 119 (% class="western" %) 120 120 121 121 ))) 122 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population 125 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 126 +(% class="western" lang="en-GB" %) 127 +(% lang="en-US" %)Elderly 128 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 129 +(% class="western" lang="en-GB" %) 130 +(% lang="en-US" %)Adults 131 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 132 +(% class="western" lang="en-GB" %) 133 +(% lang="en-US" %)Youth 134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 135 +(% class="western" lang="en-GB" %) 136 +(% lang="en-US" %)Children 137 +))) 123 123 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 124 124 (% class="western" %) 125 125 126 126 ))) 127 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)** 142 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 143 +(% class="western" lang="en-GB" style="text-align:center" %) 144 +(% lang="en-US" %)**Health status** 145 +))) 128 128 |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 129 129 (% class="western" lang="en-GB" %) 130 130 (% lang="en-US" %)Healthy 131 131 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 132 132 (% class="western" lang="en-GB" %) 133 - 151 +(% lang="en-US" %)Patient 134 134 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 135 135 (% class="western" lang="en-GB" %) 136 - 154 +(% lang="en-US" %)Rehabilitant 137 137 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 138 138 (% class="western" lang="en-GB" %) 139 - 157 +(% lang="en-US" %)Recovered/Survivor 140 140 ))) 141 141 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 142 142 (% class="western" %) 143 143 144 144 ))) 145 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)** 146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease 147 -|Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability 148 -|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) 163 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 164 +(% class="western" lang="en-GB" style="text-align:center" %) 165 +(% lang="en-US" %)**A specific disease, disorder or disability** 166 +))) 167 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 168 +(% class="western" lang="en-GB" %) 169 +(% lang="en-US" %)ADHD 170 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 171 +(% class="western" lang="en-GB" %) 172 +(% lang="en-US" %)Dementia 173 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 174 +(% class="western" lang="en-GB" %) 175 +(% lang="en-US" %)Parkinsons’ disease 176 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 177 +(% class="western" lang="en-GB" %) 178 +(% lang="en-US" %)Loneliness and Social Isolation 179 +))) 180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 181 +(% class="western" lang="en-GB" %) 182 +(% lang="en-US" %)Autism 183 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 184 +(% class="western" lang="en-GB" %) 185 +(% lang="en-US" %)Down syndrome 186 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 187 +(% class="western" lang="en-GB" %) 188 +(% lang="en-US" %)Physical disability 189 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 190 +(% class="western" lang="en-GB" %) 191 +(% lang="en-US" %)Mental health 192 +))) 193 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 194 +(% class="western" lang="en-GB" %) 195 +(% lang="en-US" %)Cardiovascular disease 196 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 197 +(% class="western" lang="en-GB" %) 198 +(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF) 199 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 200 +(% class="western" lang="en-GB" %) 201 +(% lang="en-US" %)Sleep apnea/apnea 202 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 203 +(% class="western" lang="en-GB" %) 204 +(% lang="en-US" %)Mild cognitive impairment 205 +))) 206 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 207 +(% class="western" lang="en-GB" %) 208 +(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD) 209 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 210 +(% class="western" lang="en-GB" %) 211 +(% lang="en-US" %)Language disability 212 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 213 +(% class="western" lang="en-GB" %) 214 +(% lang="en-US" %)Substance abuse (drugs, alcohol) 215 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 216 +(% class="western" lang="en-GB" %) 217 +(% lang="en-US" %)Multiple sclerosis 218 +))) 219 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 220 +(% class="western" lang="en-GB" %) 221 +(% lang="en-US" %)Cognitive disorder (mild, major) 222 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 223 +(% class="western" lang="en-GB" %) 224 +(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation 225 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 226 +(% class="western" lang="en-GB" %) 227 +(% lang="en-US" %)Trauma patient 228 + 229 +(% class="western" lang="en-GB" %) 230 +(% lang="en-US" %)(e.g., a spinal cord injury) 231 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 232 +(% class="western" lang="en-GB" %) 233 +(% lang="en-US" %)Neurodegenerative diseases 234 +))) 149 149 |(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 150 150 (% class="western" %) 151 151 152 152 ))) 153 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)** 154 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 239 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 240 +(% class="western" lang="en-GB" style="text-align:center" %) 241 +(% lang="en-US" %)**Clients of a specific service** 242 +))) 243 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 244 +(% class="western" lang="en-GB" %) 245 +(% lang="en-US" %)Child welfare 246 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 247 +(% class="western" lang="en-GB" %) 248 +(% lang="en-US" %)Nursing home 249 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 250 +(% class="western" lang="en-GB" %) 251 +(% lang="en-US" %)Employment service 252 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 155 155 (% class="western" %) 156 156 157 157 ))) 158 -| Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((256 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 159 159 (% class="western" lang="en-GB" %) 160 - 258 +(% lang="en-US" %)Early childhood education 161 161 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 162 162 (% class="western" lang="en-GB" %) 261 +(% lang="en-US" %)Home care 262 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 263 +(% class="western" lang="en-GB" %) 163 163 164 164 )))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 165 165 (% class="western" lang="en-GB" %) ... ... @@ -169,20 +169,70 @@ 169 169 (% class="western" %) 170 170 171 171 ))) 172 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)** 173 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 273 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 274 +(% class="western" lang="en-GB" style="text-align:center" %) 275 +(% lang="en-US" %)**Vulnerable groups** 276 +))) 277 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 174 174 (% class="western" lang="en-GB" %) 175 -Down Syndrome 279 +(% lang="en-US" %)Minors/Children 280 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 281 +(% class="western" lang="en-GB" %) 282 +(% lang="en-US" %)Single parents with minor children 283 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 284 +(% class="western" lang="en-GB" %) 285 +(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence 286 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 287 +(% class="western" lang="en-GB" %) 288 +(% lang="en-US" %)Substance users 289 + 290 +(% class="western" lang="en-GB" %) 291 +(% lang="en-US" %)(drugs, alcohol) 176 176 ))) 177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %) Chronical Diseases: e.g., Persons With Chronic Pulmonary(Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions(Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((293 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 178 178 (% class="western" lang="en-GB" %) 295 +(% lang="en-US" %)Disabled people 296 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 297 +(% class="western" lang="en-GB" %) 298 +(% lang="en-US" %)Victims of trafficking in human beings 299 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 300 +(% class="western" lang="en-GB" %) 301 +(% lang="en-US" %)Ethnic minorities and immigrants 302 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 303 +(% class="western" lang="en-GB" %) 304 +(% lang="en-US" %)Isolated people 305 +))) 306 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 307 +(% class="western" lang="en-GB" %) 308 +(% lang="en-US" %)Elderly people 309 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 310 +(% class="western" lang="en-GB" %) 311 +(% lang="en-US" %)Persons with serious illnesses 312 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 313 +(% class="western" lang="en-GB" %) 314 +(% lang="en-US" %)Homeless people 315 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 316 +(% class="western" lang="en-GB" %) 317 +(% lang="en-US" %)Ex-prisoners and people with criminal background 318 +))) 319 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)((( 320 +(% class="western" lang="en-GB" %) 321 +(% lang="en-US" %)Pregnant women 322 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 323 +(% class="western" lang="en-GB" %) 324 +(% lang="en-US" %)Persons with mental disorders 325 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 326 +(% class="western" lang="en-GB" %) 179 179 328 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 329 +(% class="western" lang="en-GB" %) 330 + 180 180 ))) 181 181 182 182 : 183 183 184 184 (% class="western" lang="en-GB" %) 185 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) 336 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) . 186 186 187 187 |**Researcher expertise**|**Brief use case description** 188 188 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making